24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Stock
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:53
Binance is back online after a record crypto theft. The questions are far from settled
20:53
From six-person startups to a $6.3 billion take-private: October's extraordinary month for Israeli tech exits
20:25
"Security teams are struggling to handle this AI threat"
20:24
"To build a company in Israel for the last four years is not an easy mission"
More stories
Buzz
Most popular
Daily
Weekly
1
Israeli startup Coldi is deploying AI agents to take over the cold call
2
Perion to be acquired by India’s Affle for $420 million, marking a steep fall for a once-billion-dollar Israeli company
3
ServiceNow CEO says acquired Israeli startup Sweep helps it switch CRM customers in weeks, not years
4
From six-person startups to a $6.3 billion take-private: October's extraordinary month for Israeli tech exits
5
"A gorgeous situation": ServiceNow's CEO celebrates a shrinking workforce
More news
Stock
8 stories about Stock
CTech’s Daily Israeli Tech News Roundup
04.01.18
|
CTech
Israeli regulator proposes to ban crypto-focused companies from stock exchange. Israeli military unveils intelligence fusion unit. The shekel is getting stronger.
As U.S. Domestic Issuer, Teva Reveals Top Stock Owners
03.01.18
|
Dror Reich
Kåre Schultz, the newly-appointed CEO of generic drugmaker Teva Pharmaceutical Industries Ltd., is one of Teva's largest shareholders, a Wednesday filing to the U.S. Securities and Exchange Commission revealed
Emails in Mobileye Insider Trading Case Pinpoint Leak’s Source
18.12.17
|
Tomer Ganon and Ran Abramson
The documents show how defendants communicated information about the stock’s expected spike
Israeli Defendant Denies Mobileye Insider Trading Charges
08.12.17
|
Tomer Ganon and Ran Abramson
Amir Waldman, former vice president of Israel-based medical device company Syneron Medical, is being accused by the SEC of making over $4 million from insider trading in Mobileye securities
Allergan to Sell Teva Shares to J.P. Morgan
14.11.17
|
Dror Reich and Lilach Baumer
Allergan announced it pledged its 9.8% stake in Teva to J.P. Morgan as collateral, as part of a loan agreement. The company already agreed to sell a quarter of the stock in the first quarter of 2018
MediWound Loses Stock Purchase Agreement Case
14.11.17
|
Dror Reich
The burn and wound treatment company was ordered to follow through on previous agreement to buy shares of biotech company Polyheal
Allergan Planning Sale of its Teva Stock
01.11.17
|
Dror Reich and Lilach Baumer
For the third quarter of 2017, Allergan reported an operating loss of $4.02 billion, $1.3 billion of which is due to the depreciation of its Teva securities.
Teva Offloads Holdings in Australia’s Mesoblast
25.10.17
|
Dror Reich and Lilach Baumer
The stem-cell therapy company diluted Teva’s shares through a new offering in August
Previous Articles